Report cover image

Global Nontuberculous Mycobacterium Treatment Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 27, 2023
Length 88 Pages
SKU # LPI17669961

Description

Global Nontuberculous Mycobacterium Treatment Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Nontuberculous Mycobacterium Treatment Industry Forecast” looks at past sales and reviews total world Nontuberculous Mycobacterium Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Nontuberculous Mycobacterium Treatment sales for 2023 through 2029. With Nontuberculous Mycobacterium Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nontuberculous Mycobacterium Treatment industry.

This Insight Report provides a comprehensive analysis of the global Nontuberculous Mycobacterium Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nontuberculous Mycobacterium Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nontuberculous Mycobacterium Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nontuberculous Mycobacterium Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nontuberculous Mycobacterium Treatment.

The global Nontuberculous Mycobacterium Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nontuberculous Mycobacterium Treatment players cover Insmed Incorporated, RedHill Biopharma, Novoteris, Savara and Beyond Air, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Nontuberculous Mycobacterium Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Azithromycin
Rifampin
Rifabutin
Ethambuto

Segmentation by application
Hospitals Pharmacies
Private clinics
Drug Stores and Retail Pharmacy
E-commerce

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insmed Incorporated
RedHill Biopharma
Novoteris
Savara
Beyond Air

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

88 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nontuberculous Mycobacterium Treatment Market Size 2018-2029
2.1.2 Nontuberculous Mycobacterium Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nontuberculous Mycobacterium Treatment Segment by Type
2.2.1 Azithromycin
2.2.2 Rifampin
2.2.3 Rifabutin
2.2.4 Ethambuto
2.3 Nontuberculous Mycobacterium Treatment Market Size by Type
2.3.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Type (2018-2023)
2.4 Nontuberculous Mycobacterium Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Private clinics
2.4.3 Drug Stores and Retail Pharmacy
2.4.4 E-commerce
2.5 Nontuberculous Mycobacterium Treatment Market Size by Application
2.5.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Application (2018-2023)
3 Nontuberculous Mycobacterium Treatment Market Size by Player
3.1 Nontuberculous Mycobacterium Treatment Market Size Market Share by Players
3.1.1 Global Nontuberculous Mycobacterium Treatment Revenue by Players (2018-2023)
3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Nontuberculous Mycobacterium Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nontuberculous Mycobacterium Treatment by Regions
4.1 Nontuberculous Mycobacterium Treatment Market Size by Regions (2018-2023)
4.2 Americas Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
4.3 APAC Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
4.4 Europe Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nontuberculous Mycobacterium Treatment Market Size by Country (2018-2023)
5.2 Americas Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
5.3 Americas Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nontuberculous Mycobacterium Treatment Market Size by Region (2018-2023)
6.2 APAC Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
6.3 APAC Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nontuberculous Mycobacterium Treatment by Country (2018-2023)
7.2 Europe Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nontuberculous Mycobacterium Treatment by Region (2018-2023)
8.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nontuberculous Mycobacterium Treatment Market Forecast
10.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2024-2029)
10.1.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Nontuberculous Mycobacterium Treatment Forecast
10.1.3 APAC Nontuberculous Mycobacterium Treatment Forecast
10.1.4 Europe Nontuberculous Mycobacterium Treatment Forecast
10.1.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast
10.2 Americas Nontuberculous Mycobacterium Treatment Forecast by Country (2024-2029)
10.2.1 United States Nontuberculous Mycobacterium Treatment Market Forecast
10.2.2 Canada Nontuberculous Mycobacterium Treatment Market Forecast
10.2.3 Mexico Nontuberculous Mycobacterium Treatment Market Forecast
10.2.4 Brazil Nontuberculous Mycobacterium Treatment Market Forecast
10.3 APAC Nontuberculous Mycobacterium Treatment Forecast by Region (2024-2029)
10.3.1 China Nontuberculous Mycobacterium Treatment Market Forecast
10.3.2 Japan Nontuberculous Mycobacterium Treatment Market Forecast
10.3.3 Korea Nontuberculous Mycobacterium Treatment Market Forecast
10.3.4 Southeast Asia Nontuberculous Mycobacterium Treatment Market Forecast
10.3.5 India Nontuberculous Mycobacterium Treatment Market Forecast
10.3.6 Australia Nontuberculous Mycobacterium Treatment Market Forecast
10.4 Europe Nontuberculous Mycobacterium Treatment Forecast by Country (2024-2029)
10.4.1 Germany Nontuberculous Mycobacterium Treatment Market Forecast
10.4.2 France Nontuberculous Mycobacterium Treatment Market Forecast
10.4.3 UK Nontuberculous Mycobacterium Treatment Market Forecast
10.4.4 Italy Nontuberculous Mycobacterium Treatment Market Forecast
10.4.5 Russia Nontuberculous Mycobacterium Treatment Market Forecast
10.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Nontuberculous Mycobacterium Treatment Market Forecast
10.5.2 South Africa Nontuberculous Mycobacterium Treatment Market Forecast
10.5.3 Israel Nontuberculous Mycobacterium Treatment Market Forecast
10.5.4 Turkey Nontuberculous Mycobacterium Treatment Market Forecast
10.5.5 GCC Countries Nontuberculous Mycobacterium Treatment Market Forecast
10.6 Global Nontuberculous Mycobacterium Treatment Forecast by Type (2024-2029)
10.7 Global Nontuberculous Mycobacterium Treatment Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Insmed Incorporated
11.1.1 Insmed Incorporated Company Information
11.1.2 Insmed Incorporated Nontuberculous Mycobacterium Treatment Product Offered
11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Insmed Incorporated Main Business Overview
11.1.5 Insmed Incorporated Latest Developments
11.2 RedHill Biopharma
11.2.1 RedHill Biopharma Company Information
11.2.2 RedHill Biopharma Nontuberculous Mycobacterium Treatment Product Offered
11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 RedHill Biopharma Main Business Overview
11.2.5 RedHill Biopharma Latest Developments
11.3 Novoteris
11.3.1 Novoteris Company Information
11.3.2 Novoteris Nontuberculous Mycobacterium Treatment Product Offered
11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novoteris Main Business Overview
11.3.5 Novoteris Latest Developments
11.4 Savara
11.4.1 Savara Company Information
11.4.2 Savara Nontuberculous Mycobacterium Treatment Product Offered
11.4.3 Savara Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Savara Main Business Overview
11.4.5 Savara Latest Developments
11.5 Beyond Air
11.5.1 Beyond Air Company Information
11.5.2 Beyond Air Nontuberculous Mycobacterium Treatment Product Offered
11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Beyond Air Main Business Overview
11.5.5 Beyond Air Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us